Charles River Laboratories International Inc (NYSE:CRL)
$ 214.2 25.52 (13.53%) Market Cap: 10.95 Bil Enterprise Value: 13.50 Bil PE Ratio: 25.59 PB Ratio: 2.97 GF Score: 87/100

Q4 2020 Charles River Laboratories International Inc Earnings Call Transcript

Feb 17, 2021 / 01:30PM GMT
Release Date Price: $299.48 (+4.44%)
Operator

Ladies and gentlemen, thank you for standing by, and welcome to Charles River Laboratories International Fourth Quarter Earnings Conference Call and 2021 Guidance Call. (Operator Instructions) Please be advised today's conference is being recorded. (Operator Instructions)

I'd like to hand the conference over to your speaker today, Mr. Todd Spencer, Corporate Vice President of Investor Relations with Charles River. Please go ahead.

Todd Spencer
Charles River Laboratories International, Inc. - Corporate VP of IR

Thank you, Mary. Good morning, and welcome to Charles River Laboratories Fourth Quarter 2020 Earnings and 2021 Guidance Conference Call and Webcast. This morning, Jim Foster, Chairman, President and Chief Executive Officer; and David Smith, Executive Vice President and Chief Financial Officer, will comment on our results for the fourth quarter and full year 2020 and our guidance for 2021 as well as our planned acquisition of Cognate BioServices. Following the presentation, they will respond to questions.

There is a slide presentation

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot